Circulating levels of glucoselysine, a fructose-specific glycation product, are modulated by dietary fructose; post-hoc analysis of a case-control study and a randomized controlled trial.
Measuring specific fructose markers in blood may help identify people at higher cardiometabolic risk from dietary fructose consumption.
BACKGROUND: Fructose consumption has been associated with cardiometabolic disease, including type 2 diabetes and cardiovascular disease. STUDY REGISTRATION: The FRUITLESS study was registered at https://clinicaltrials.gov/study/NCT03067428, identifier: NCT03067428.
What the study was
- Study design
- Randomized Controlled Trial
- Category
- Prevention
- Maturity
- Potentially Practice-Changing
- Journal
- The American journal of clinical nutrition
Why it surfaced
Score 7/10; Design: Randomized Controlled Trial; Topics: Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.